Overview Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS) Status: Completed Trial end date: 2019-06-17 Target enrollment: Participant gender: Summary Two-centre, double-blind, placebo-controlled, randomized, and multiple-dose clinical study. Phase: Phase 2 Details Lead Sponsor: SanionaTreatments: Metoprolol